It’s estimated that more than 5.8 million people in the UK are living with diabetes, which is an all-time high, according to Diabetes UK

The 72-week multinational phase 3 ATTAIN-2 trial randomized 1613 participants with obesity or overweight (BMI ≥ 27.0) and T2D to either 6 mg, 12 mg, or 36 mg orforglipron or placebo. Overall, 89.5% completed the study, with similar rates across groups.

Diabetes has reached an all-time high despite a “statistically meaningful decrease” in the adult obesity rate, Gallup reported.

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker. Lilly said Thursday that its top-selling drugs,

The US government is tightening visa and Green Card rules for applicants with certain health conditions, including diabetes, obesity, and heart disease. Officials cite concerns over long-term healthcare costs and public health implications.

Obesity products gain momentum in India and globally as multinationals leverage smart pricing and collaborations amidst emerging generics

P resident Donald Trump is adjusting his messaging strategy to win over voters who are worried about the cost of living with plans to emphasize new tax breaks and show progress on fighting inflation.

Donald Trump's move to cut drug prices in America can potentially turn out to be a $35 billion additional cost to the federal government over the years. Here's what the Trump administration announced related to drug prices in America.